Ketamine Shows Promise in Treating Severe Depression: Insights from a Recent Study.

A recent study across four major U.S. medical institutions indicates that ketamine infusions may effectively alleviate severe depression symptoms, including suicidality, in individuals resistant to conventional treatments. With a focus on uncovering blood-based biomarkers of treatment response, the study revealed significant remission rates and reduced suicidal ideation among participants. While well-tolerated, the study lacks a control group and awaits further analysis of potential biological markers associated with treatment response. Despite limitations, the findings underscore ketamine's potential as a rapid and effective treatment for refractory depression.